Compare Revvity Inc (RVTY) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Revvity Inc trades at $110.1 (market cap $11.87B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.65. The key difference: Revvity Inc pays a 0.26% dividend while Vanguard Sht-Term Inflation-Protected Sec Idx ETF pays none, and Revvity Inc is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals.
| RVTY | VTIP | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | — |
52-Week High | $117.75 | $50.75 |
52-Week Low | $82.26 | $49.39 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
VTIP trades at $49.63, down 0.14% with a bearish technical signal. The Vanguard Short-Term Inflation-Protected Securities ETF provides inflation protection through short-term TIPS, offering an expected 3.8% return amid current inflation levels. Recent institutional activity shows mixed positioning with some firms increasing holdings while others trim positions.
The ETF presents a defensive play against persistent inflation above the Fed's 2% target, though rising interest rates pose valuation risks. Short duration reduces interest rate sensitivity compared to longer-term bonds, making it suitable for inflation-hedging portfolios in the current economic environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
